Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Pfizer Stock Just Popped


Pfizer (NYSE: PFE) stock was trading 3.6% higher as of 12:01 p.m. ET Tuesday after The Washington Post reported that the Trump administration had struck a deal with the pharmaceutical giant under which it will sell some drugs to Medicaid patients at reduced prices.

Image source: Getty Images.

President Donald Trump signed an executive order in May ordering the government to negotiate new pricing with U.S. drugmakers, such that they charge no more to U.S. customers than they do to patients in other wealthy nations. Step one of the plan that order laid out involves attempting to get drug companies to lower prices voluntarily -- with the implication that step two might involve the government imposing mandatory price cuts.

Continue reading


Source Fool.com

Pfizer Inc. Stock

€21.88
1.040%
There is an upward development for Pfizer Inc. compared to yesterday, with an increase of €0.23 (1.040%).
With 13 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 27 € there is a positive potential of 23.4% for Pfizer Inc. compared to the current price of 21.88 €.
Like: 0
PFE
Share

Comments